LFA-1/ICAM interaction inhibitors (Biogen Idec)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameLFA-1/ICAM interaction inhibitors (Biogen Idec)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntercellular adhesion molecule-1 modulatorsLeukocyte adhesion glycoprotein LFA-1 alpha modulators

TargetsLeukocyte adhesion glycoprotein LFA-1 alphaIntercellular adhesion molecule-1

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiogen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiogen Inc

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

ATC CodeN/A